The Plasmid-Encoded pGP3 PromotesChlamydiaEvasion of Acidic Barriers in Both Stomach and Vagina
ABSTRACTAlthoughChlamydia trachomatisis a human genital tract pathogen, chlamydial organisms have frequently been detected in both vaginal and rectal swab samples of animals and humans. The plasmid-encoded pGP3, a genital tract virulence factor, is essential forChlamydia muridarumto colonize the mouse gastrointestinal tract. However, intracolon inoculation to bypass the gastric barrier rescued the colonization ability of a pGP3-deficientC. muridarummutant, suggesting that pGP3 is required forC. muridarumto reach but not to colonize the large intestine. The pGP3-deficient mutant was rapidly cleared in the stomach and was 100-fold more susceptible to gastric killing. In mice genetically deficient in gastrin, a key regulator for gastric acid production, or pharmacologically treated with a proton pump inhibitor, the ability of pGP3-deficientC. muridarumto colonize the gastrointestinal tract was rescued. The pGP3-dependent resistance was further recapitulatedin vitrowith treatments with HCl, pepsin, or sarkosyl. In the genital tract, deficiency in pGP3 significantly reducedC. muridarumsurvival in the mouse vagina and increasedC. muridarumsusceptibility to vaginal killing by ∼8 times. The pGP3-deficientC. muridarumwas more susceptible to lactic acid killing, and the pGP3 deficiency also significantly increasedC. trachomatissusceptibility to lactic acid. The above-described observations together suggest thatChlamydiamay have acquired the plasmid-encoded pGP3 to overcome the gastric barrier during its adaptation to the gastrointestinal tract and the pGP3-dependent resistance may enable chlamydial evasion of the female lower genital tract barrier during sexual transmission.